LISCASTOBART
UNII VNS9LT4XDB

Substance Identification & Data

This profile provides standardized clinical and technical data for Liscastobart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VNS9LT4XDB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2785392-78-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

VNS9LT4XDB

CAS Registry Number

2785392-78-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LISCASTOBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C185390

National Cancer Institute reference terminology for clinical and research data.

INN ID

13585

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Liscastobart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LISCASTOBART

Common Names & Synonyms

H-GAMMA4 HEAVY CHAIN HUMANIZED (1-447) (VH (HOMO SAPIENS IGHV1-2*02 (79.4%) -(IGHD) -IGHJ4*01 (78.6%) L123>T (115), CDR-IMGT (8.8.13) (26-33.51-58.97-109)) (1-120) -HOMO SAPIENS IGHG4*01, NG4M(A) CH2 L92, 12-G4V5 H P10 (CH1 (121-218), HINGE 1-12 S10>P (228) (219-230), CH2 L92 (309) (231-340), CH3 (341-445), CHS (446-447)) (121-447)), (134-218')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HUMANIZED (1'-218') (V-KAPPA (HOMO SAPIENS IGKV3D-11*01 (85.1%) -IGKJ4*01 (100%), CDR-IMGT (10.3.9)(27'-36'.54'-56'.93'-101')) (1'-111') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (157'), V101 (195')) (112'-218')); DIMER (226-226'':229-229'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1

IMMUNOGLOBULIN G4 (228-PROLINE), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS MONOCLONAL BAT1308 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BAT1308 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), HUMANIZED MONOCLONAL ANTIBODY (LISCASTOBART)

LISCASTOBART [INN]